Abbott Issues New Cybersecurity Patch For Cardiac Devices

Following concerns about potential cybersecurity vulnerabilities on certain Abbott Laboratories Inc. implantable cardiac devices, US FDA has alerted patients and health-care providers to another firmware rolled out by the company to mitigate those risks. The firmware also tackles problems with premature battery depletion, which the agency says is unrelated to the cybersecurity concerns.

In 2016, Muddy Waters Research, a short-sale trading company, published research it had conducted with MedSec Holdings Ltd. that found serious vulnerabilities in certain St. Jude Medical cardiac devices that...